Simi Ali
Applied Immunobiology and Transplantation Group
Institute of Cellular Medicine
Medical School
University of Newcastle Upon Tyne
UK
Name/email consistency: high
- Therapy with nonglycosaminoglycan-binding mutant CCL7: a novel strategy to limit allograft inflammation. Ali, S., O'Boyle, G., Hepplewhite, P., Tyler, J.R., Robertson, H., Kirby, J.A. Am. J. Transplant. (2010)
- Leukocyte extravasation: an immunoregulatory role for alpha-L-fucosidase? Ali, S., Jenkins, Y., Kirkley, M., Dagkalis, A., Manivannan, A., Crane, I.J., Kirby, J.A. J. Immunol. (2008)
- An apparent paradox: chemokine receptor agonists can be used for anti-inflammatory therapy. Ali, S., O'Boyle, G., Mellor, P., Kirby, J.A. Mol. Immunol. (2007)
- Chemokines: novel targets for breast cancer metastasis. Ali, S., Lazennec, G. Cancer Metastasis Rev. (2007)
- Renal transplantation: examination of the regulation of chemokine binding during acute rejection. Ali, S., Malik, G., Burns, A., Robertson, H., Kirby, J.A. Transplantation (2005)
- A non-glycosaminoglycan-binding variant of CC chemokine ligand 7 (monocyte chemoattractant protein-3) antagonizes chemokine-mediated inflammation. Ali, S., Robertson, H., Wain, J.H., Isaacs, J.D., Malik, G., Kirby, J.A. J. Immunol. (2005)
- Contribution of the putative heparan sulfate-binding motif BBXB of RANTES to transendothelial migration. Ali, S., Fritchley, S.J., Chaffey, B.T., Kirby, J.A. Glycobiology (2002)
- Examination of the function of RANTES, MIP-1alpha, and MIP-1beta following interaction with heparin-like glycosaminoglycans. Ali, S., Palmer, A.C., Banerjee, B., Fritchley, S.J., Kirby, J.A. J. Biol. Chem. (2000)
